Atropos Health Announces $14M Series A, Taps Co-Founder As Ceo

Atropos Health, the leader in providing physicians with research-grade real-world evidence at the point of care, has announced the completion of a $14M Series A funding round. The company will use the funds to expand its commercial team, further build on recent market traction, and continue to develop its oncology product. Breyer Capital, a global venture capital investor, led the round with participation from Emerson Collective, a multi-stage venture team focused on accelerating companies positively impacting the world. Other participating investors include Boston Millennia Partners.